Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro

We studied the effects of luteinising hormone-releasing hormone (LHRH) agonist leuproreline (1 microM for 96 h) and LHRH antagonist cetrorelix on the cell growth of primary cultures from nine human endometrial cancers using the sulphorhodamine colorimetric test. Histological examinations and reverse...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer letters 2000-03, Vol.150 (1), p.71-78
Hauptverfasser:	NOCI, I, CORONNELLO, M, ARCANGELI, A, MINI, E, TADDEI, G, BORRI, P, BORRANI, E, GIACHI, M, CHIEFFI, O, MARCHIONNI, M, PAGLIERANI, M, BUCCOLIERO, A. M, CHERUBINI, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic agents Biological and medical sciences Cell Division - drug effects Chemotherapy Endometrial Neoplasms - genetics Endometrial Neoplasms - pathology Endometrial Neoplasms - prevention & control Female Gonadotropin-Releasing Hormone - analogs & derivatives Gonadotropin-Releasing Hormone - pharmacology Humans Leuprolide - pharmacology Medical sciences Middle Aged Pharmacology. Drug treatments Postmenopause Receptors, LHRH - genetics Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - genetics Tumor Cells, Cultured
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!